Back to 
FIRST MANHATTAN CO. LLC.
FIRST MANHATTAN CO. LLC.
PTGX
Showing 0 of 2 quarters
Position history for FIRST MANHATTAN CO. LLC.'s holdings in PROTAGONIST THERAPEUTICS INC
No. First Manhattan exited its PTGX (Protagonist Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 55,800 shares worth $441,000. First Manhattan first reported PTGX in Q2 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.